NO953347L - Triglyserid kontrastmiddel - Google Patents
Triglyserid kontrastmiddelInfo
- Publication number
- NO953347L NO953347L NO953347A NO953347A NO953347L NO 953347 L NO953347 L NO 953347L NO 953347 A NO953347 A NO 953347A NO 953347 A NO953347 A NO 953347A NO 953347 L NO953347 L NO 953347L
- Authority
- NO
- Norway
- Prior art keywords
- groups
- pct
- date sep
- sec
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/96—Esters of carbonic or haloformic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
- C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
- C07C69/30—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with trihydroxylic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Forbindelser av formel (I) CHj-OR1 l CH-OR2 l CH2OR3 hvor R1, R2 og R3 er uavhengig valgt fra: (i) mettede eller umettede fettsyregrupper, fortrinnsvis med 14 til 24 karbonatomer, aller helst av en type funnet i naturen; (ii) grupper av formel -C-O-CR<Rs-O-C-(O)n-A-R6 hvor R4 og R5 er uavhengig valgt fra hydrogen- atomer, ¿,.4 alkylgrupper og arylgrupper, fortrinnsvis Q.10 arylgrupper, n representerer heltallene O eller l, A representerer enten en kjemisk binding eller en rett eller forgrenet Cw alkylenkjede og Rs er en trijodert fenylgruppe som også kan bære andre substituenter.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939303992A GB9303992D0 (en) | 1993-02-26 | 1993-02-26 | Contrast agents |
PCT/GB1994/000375 WO1994019025A2 (en) | 1993-02-26 | 1994-02-25 | Contrast agents |
Publications (2)
Publication Number | Publication Date |
---|---|
NO953347D0 NO953347D0 (no) | 1995-08-25 |
NO953347L true NO953347L (no) | 1995-09-15 |
Family
ID=10731141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO953347A NO953347L (no) | 1993-02-26 | 1995-08-25 | Triglyserid kontrastmiddel |
Country Status (9)
Country | Link |
---|---|
US (1) | US5767299A (no) |
EP (1) | EP0686046B1 (no) |
JP (1) | JP3558223B2 (no) |
AT (1) | ATE193209T1 (no) |
DE (1) | DE69424655T2 (no) |
ES (1) | ES2145824T3 (no) |
GB (1) | GB9303992D0 (no) |
NO (1) | NO953347L (no) |
WO (1) | WO1994019025A2 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20100033405A (ko) | 2007-07-12 | 2010-03-29 | 지이 헬스케어 에이에스 | 조영제 |
ES2413160T3 (es) | 2007-10-12 | 2013-07-15 | Ge Healthcare As | Agentes de contraste |
WO2009047319A1 (en) | 2007-10-12 | 2009-04-16 | Ge Healthcare As | Contrast agents |
JP2011500530A (ja) | 2007-10-12 | 2011-01-06 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 造影剤 |
JP2011500532A (ja) | 2007-10-12 | 2011-01-06 | ジーイー・ヘルスケア・アクスイェ・セルスカプ | 造影剤 |
US11065201B2 (en) | 2014-11-21 | 2021-07-20 | Technical University Of Denmark | Gel formulations for local drug release |
CN109475491B (zh) | 2016-05-20 | 2022-06-24 | 丹麦技术大学 | 可触诊的标记物组合物 |
JP6867639B2 (ja) * | 2016-10-11 | 2021-05-12 | 学校法人 聖マリアンナ医科大学 | 非イオン性ヨード造影剤の結合体 |
EP3982922A1 (en) | 2019-06-12 | 2022-04-20 | Technical University of Denmark | Dissacharide formulations for controlled drug release |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4052439A (en) * | 1976-04-30 | 1977-10-04 | Abbott Laboratories | Carboxylic esters of phosphonoacetic acid |
DE3407473C2 (de) * | 1984-02-29 | 1986-01-30 | Dr. Franz Köhler Chemie GmbH, 6146 Alsbach | N,N-[(3,5-Diacetamido-2,4,6-triiodbenzoyl)-aminoacyl]-N-methylglucamide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Röntgenkontrastmittel |
US4567034A (en) * | 1984-09-07 | 1986-01-28 | E. R. Squibb & Sons, Inc. | Esters of diatrizoic acid as X-ray contrast agents |
JPS6445351A (en) * | 1987-08-12 | 1989-02-17 | Mitsui Toatsu Chemicals | Purification of 3,5-diamino-2,4,6-triiodobenzoic acid acyl derivative |
ES2006961A6 (es) * | 1988-05-26 | 1989-05-16 | Juste Sa | Procedimiento para la preparacion de agentes iodados de contraste a los rayos x. |
EP0436316A1 (en) * | 1989-12-08 | 1991-07-10 | Milos Sovak | X-ray contrast media for prolonged opacification |
ES2021944A6 (es) * | 1990-02-14 | 1991-11-16 | Rhone Poulenc Farma Sa | Procedimiento para preparar nuevos derivados de 1,3,5,-triamino-2,4,6-triyodobenceno. |
AU642066B2 (en) * | 1991-01-25 | 1993-10-07 | Nanosystems L.L.C. | X-ray contrast compositions useful in medical imaging |
US5233995A (en) * | 1991-11-21 | 1993-08-10 | Sterling Winthrop Inc. | Encapsulated particles useful as contrast agents in ultrasound and x-ray imaging compositions and methods |
-
1993
- 1993-02-26 GB GB939303992A patent/GB9303992D0/en active Pending
-
1994
- 1994-02-25 ES ES94907630T patent/ES2145824T3/es not_active Expired - Lifetime
- 1994-02-25 EP EP94907630A patent/EP0686046B1/en not_active Expired - Lifetime
- 1994-02-25 DE DE69424655T patent/DE69424655T2/de not_active Expired - Lifetime
- 1994-02-25 JP JP51877594A patent/JP3558223B2/ja not_active Expired - Lifetime
- 1994-02-25 US US08/507,296 patent/US5767299A/en not_active Expired - Lifetime
- 1994-02-25 WO PCT/GB1994/000375 patent/WO1994019025A2/en active IP Right Grant
- 1994-02-25 AT AT94907630T patent/ATE193209T1/de not_active IP Right Cessation
-
1995
- 1995-08-25 NO NO953347A patent/NO953347L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JPH08506829A (ja) | 1996-07-23 |
WO1994019025A3 (en) | 1994-10-13 |
JP3558223B2 (ja) | 2004-08-25 |
ATE193209T1 (de) | 2000-06-15 |
EP0686046B1 (en) | 2000-05-24 |
EP0686046A1 (en) | 1995-12-13 |
GB9303992D0 (en) | 1993-04-14 |
ES2145824T3 (es) | 2000-07-16 |
NO953347D0 (no) | 1995-08-25 |
US5767299A (en) | 1998-06-16 |
DE69424655D1 (de) | 2000-06-29 |
DE69424655T2 (de) | 2001-02-08 |
WO1994019025A2 (en) | 1994-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU9500503D0 (en) | Derivatives of valproic and 2-valproenoic acid amides and use anticonvulsants | |
DK0588869T3 (da) | Røntgenkontrastmiddel | |
DE69127290D1 (de) | Arzneimittelfreisetzungssystem aus porphyrinzusammensetzungen und verfahren zu deren verwendung | |
IL114794A0 (en) | Peptidic compounds analogous to distramycin process for their preparation and their use | |
ATE147272T1 (de) | Pharmazeutische zubereitungsformen | |
DE69528437D1 (de) | Substituierte azaindolylidenderivate und verfahren zu ihrer herstellung | |
NO953347D0 (no) | Triglyserid kontrastmiddel | |
GB2269589B (en) | 3-Hydroxy-pyridin-4-ones and their use in pharmaceutical compositions | |
DE59002863D1 (de) | Lysolecithinderivate zur behandlung von autoimmunerkrankungen. | |
DE69200168D1 (de) | Polyjodverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende Kontrastmittel. | |
IL113665A0 (en) | Amide derivatives their preparation pharmaceutical compositions containing them and their use | |
DE69018730D1 (de) | Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
PT79969A (de) | Isoxazol-derivate verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel | |
KR930703013A (ko) | 항당뇨병제로서 유용한 신규한 글루코하이드롤라제 억제제 | |
ATE144766T1 (de) | Nichtionische jodhaltige röntgenstrahlenkontrastmittel, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen | |
GR3029692T3 (en) | Novel phosphane oxides, method of preparing them and drugs containing these compounds | |
BE896635A (fr) | Compositions pharmaceutiques analgesiques contenant des 5-phenyl-1,4-benzodiazepines. | |
GR3035010T3 (en) | New derivatives of glycylanilides, preparation and therapeutical application | |
ATE167873T1 (de) | Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |